SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-21-004564
Filing Date
2021-04-21
Accepted
2021-04-21 17:11:04
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20210421xs3.htm S-3 472421
2 EX-5.1 tmb-20210421xex5d1.htm EX-5.1 14667
3 EX-23.1 tmb-20210421xex23d1.htm EX-23.1 4857
4 GRAPHIC tmb-20210421xex5d1001.jpg GRAPHIC 4092
5 GRAPHIC tmb-20210421xex5d1002.jpg GRAPHIC 3718
6 GRAPHIC tmb-20210421xs3009.jpg GRAPHIC 5849
  Complete submission text file 0001558370-21-004564.txt   512312
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255418 | Film No.: 21842435
SIC: 2834 Pharmaceutical Preparations